| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |